重组人表皮生长因子与小牛血去蛋白提取物滴眼液对白内障超声乳化术后角膜水肿的影响

摘要

目的:比较分析重组人表皮生长因子滴眼液与小牛血去蛋白提取物滴眼液对白内障超声乳化术后角膜水肿的影响.方法:随机数字法将72例72眼行白内障超声乳化术的患者分为观察组与对照组,观察组术后给予小牛血去蛋白提取物滴眼液治疗,对照组则行重组人表皮生长因子滴眼液干预,比较两组术后不同时间点角膜水肿程度、自觉症状评分、角膜内皮细胞计数、角膜厚度变化及术后视力恢复情况.结果:与术后1d比较,两组术后7d角膜水肿程度均显著改善,差异有统计学意义(P0郾05);与术后1d比较,两组术后7d自觉症状评分均显著下降,差异有统计学意义(P0郾05),对照组较术前相比,有统计学差异(P0.05).Compared with 1d after surgery,the subjective symptom score and corneal thickness of the two groups significantly decreased on the 7th day after surgery (P<0.05).At 7d after surgery,the above indexes were significantly better in the observation group than the control group(P<0.05).At 1mo after surgery,the corneal endothelium count was significantly larger in the observation group than the control group (P<0.001).CONCLUSION:Both of recombinant human epidermal growth factor eye drops and deproteinized calf blood extract eye drops can significantly relieve corneal edema and improve visual acuity of patients after phacoemulsification.However,the latter has obvious advantages over the former in the repair of corneal endothelial cell injury after surgery.